Landaas & CO Johnson & Johnson Transaction History

Landaas & CO

$327 Million
Q2 2024

A detailed history of Landaas & CO transactions in Johnson & Johnson stock. As of the latest transaction made, Landaas & CO holds 1,924 shares of JNJ stock, worth $311,803. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,924

Previous 1,823 5.54%

Holding current value

$311,803

Previous $288,000 2.43%

% of portfolio

0.09%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $14,582 - $15,935	101 Added 5.54%	1,924 $281,000
Q1 2024 May 09, 2024	SELL	$155.22 - $162.74 $2,793 - $2,929	-18 Reduced 0.98%	1,823 $288,000
Q4 2023 Feb 12, 2024	SELL	$145.6 - $158.88 $163,217 - $178,104	-1,121 Reduced 37.85%	1,841 $288,000
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $14,173 - $15,877	-91 Reduced 2.98%	2,962 $461,000
Q2 2023 Aug 03, 2023	BUY	$154.35 - $166.11 $2,315 - $2,491	15 Added 0.49%	3,053 $505,000
Q1 2023 May 10, 2023	BUY	$151.05 - $180.26 $75,373 - $89,949	499 Added 19.65%	3,038 $470,000
Q4 2022 Feb 15, 2023	SELL	$160.2 - $179.79 $172,054 - $193,094	-1,074 Reduced 29.73%	2,539 $448,000
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $27,748 - $30,877	-172 Reduced 4.54%	3,613 $590,000
Q2 2022 Aug 09, 2022	BUY	$168.19 - $186.01 $168 - $186	1 Added 0.03%	3,785 $672,000
Q4 2021 Mar 03, 2022	BUY	$155.93 - $173.01 $155 - $173	1 Added 0.03%	3,784 $647,000
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $7,267 - $8,076	45 Added 1.2%	3,783 $611,000
Q2 2021 Aug 17, 2021	BUY	$159.48 - $171.07 $1,275 - $1,368	8 Added 0.21%	3,738 $616,000
Q1 2021 May 11, 2021	BUY	$153.07 - $170.48 $1,071 - $1,193	7 Added 0.19%	3,730 $613,000
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $1,096 - $1,259	8 Added 0.22%	3,723 $586,000
Q3 2020 Nov 06, 2020	SELL	$140.38 - $153.83 $27,093 - $29,689	-193 Reduced 4.94%	3,715 $553,000
Q2 2020 Aug 04, 2020	BUY	$128.81 - $155.51 $901 - $1,088	7 Added 0.18%	3,908 $550,000
Q1 2020 May 05, 2020	SELL	$111.14 - $153.99 $13,225 - $18,324	-119 Reduced 2.96%	3,901 $570,000
Q4 2019 Feb 13, 2020	BUY	$127.5 - $146.44 $128,392 - $147,465	1,007 Added 33.42%	4,020 $586,000
Q3 2019 Oct 30, 2019	SELL	$126.95 - $142.14 $18,915 - $21,178	-149 Reduced 4.71%	3,013 $390,000
Q2 2019 Jul 29, 2019	BUY	$131.15 - $144.24 $131 - $144	1 Added 0.03%	3,162 $440,000
Q1 2019 Apr 19, 2019	BUY	$125.72 - $139.79 $341,832 - $380,089	2,719 Added 615.16%	3,161 $442,000
Q1 2019 Apr 18, 2019	SELL	$125.72 - $139.79 $341,832 - $380,089	-2,719 Reduced 86.02%	442 $442,000
Q4 2018 Feb 05, 2019	SELL	$122.84 - $147.84 $30,710 - $36,960	-250 Reduced 7.33%	3,161 $408,000
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $21,276 - $25,004	-175 Reduced 4.88%	3,411 $471,000
Q2 2018 Aug 07, 2018	SELL	$119.4 - $131.76 $11,940 - $13,176	-100 Reduced 2.71%	3,586 $435,000
Q1 2018 May 14, 2018	SELL	$125.1 - $148.14 $18,765 - $22,220	-150 Reduced 3.91%	3,686 $472,000
Q4 2017 Feb 06, 2018	SELL	$131.22 - $143.62 $95,528 - $104,555	-728 Reduced 15.95%	3,836 $536,000
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $590,901 - $617,874	4,564	4,564 $593,000

Others Institutions Holding JNJ

# of Institutions

4,162

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $424B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Landaas & CO , based on Form 13F filings with the SEC.

News

Stay updated on Landaas & CO with notifications on news.

Account